These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 26513200)

  • 1. Dendritic cell targeted vaccines: Recent progresses and challenges.
    Chen P; Liu X; Sun Y; Zhou P; Wang Y; Zhang Y
    Hum Vaccin Immunother; 2016 Mar; 12(3):612-22. PubMed ID: 26513200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting human dendritic cells in situ to improve vaccines.
    Sehgal K; Dhodapkar KM; Dhodapkar MV
    Immunol Lett; 2014 Nov; 162(1 Pt A):59-67. PubMed ID: 25072116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an Antigen Delivery System for a B Cell-Targeted Vaccine as an Alternative to Dendritic Cell-Targeted Vaccines.
    Shimizu T; Kawaguchi Y; Ando H; Ishima Y; Ishida T
    Chem Pharm Bull (Tokyo); 2022; 70(5):341-350. PubMed ID: 35491190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models.
    Kretz-Rommel A; Qin F; Dakappagari N; Torensma R; Faas S; Wu D; Bowdish KS
    J Immunother; 2007 Oct; 30(7):715-26. PubMed ID: 17893564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells: translating innate to adaptive immunity.
    Steinman RM; Hemmi H
    Curr Top Microbiol Immunol; 2006; 311():17-58. PubMed ID: 17048704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Barramundi (Lates calcarifer) DC-SCRIPT, a Specific Molecular Marker for Dendritic Cells in Fish.
    Zoccola E; Delamare-Deboutteville J; Barnes AC
    PLoS One; 2015; 10(7):e0132687. PubMed ID: 26173015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells: master regulators of the immune response.
    Mellman I
    Cancer Immunol Res; 2013 Sep; 1(3):145-9. PubMed ID: 24777676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New understanding of immunological mechanisms.
    Saalmüller A
    Vet Microbiol; 2006 Oct; 117(1):32-8. PubMed ID: 16701965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vibrio cholerae ghosts (VCG) exert immunomodulatory effect on dendritic cells for enhanced antigen presentation and induction of protective immunity.
    Eko FO; Mania-Pramanik J; Pais R; Pan Q; Okenu DM; Johnson A; Ibegbu C; He C; He Q; Russell R; Black CM; Igietseme JU
    BMC Immunol; 2014 Dec; 15():584. PubMed ID: 25551828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-targeted vaccines--hope or hype?
    Kastenmüller W; Kastenmüller K; Kurts C; Seder RA
    Nat Rev Immunol; 2014 Oct; 14(10):705-11. PubMed ID: 25190285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
    Klippstein R; Pozo D
    Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells and other innate determinants of T helper cell polarisation.
    Walsh KP; Mills KH
    Trends Immunol; 2013 Nov; 34(11):521-30. PubMed ID: 23973621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen delivery by dendritic cells.
    Moll H
    Int J Med Microbiol; 2004 Oct; 294(5):337-44. PubMed ID: 15532992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines.
    Tacken PJ; Figdor CG
    Semin Immunol; 2011 Feb; 23(1):12-20. PubMed ID: 21269839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo assessment of in vivo DC-targeted antibodies in pre-clinical models.
    Huang Q; Anandasabapathy N
    Methods Enzymol; 2020; 632():417-430. PubMed ID: 32000908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells and their role in cancer immunotherapy.
    Jalili A
    Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.
    Kranz LM; Diken M; Haas H; Kreiter S; Loquai C; Reuter KC; Meng M; Fritz D; Vascotto F; Hefesha H; Grunwitz C; Vormehr M; Hüsemann Y; Selmi A; Kuhn AN; Buck J; Derhovanessian E; Rae R; Attig S; Diekmann J; Jabulowsky RA; Heesch S; Hassel J; Langguth P; Grabbe S; Huber C; Türeci Ö; Sahin U
    Nature; 2016 Jun; 534(7607):396-401. PubMed ID: 27281205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.